Antibiotic resistance is the most challenging clinical and public health problem. Despite of
living in the era of novel technologies in biomedical research, many of untreatable infectious …

Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Polymyxins have recently been re-introduced into the therapeutic arsenal to combat
infections caused by multidrug-resistant Gram-negative bacteria. However, the emergence …

Acinetobacter is a complex genus, and historically, there has been confusion about the
existence of multiple species. The species commonly cause nosocomial infections …

We compared six colistin susceptibility testing (ST) methods on 61 carbapenem-
nonsusceptible Klebsiella pneumoniae (n= 41) and Acinetobacter baumannii (n= 20) clinical …

Background We evaluated the association between mortality and colistin resistance in
Acinetobacter baumannii infections and the interaction with antibiotic therapy. Methods This …

Background Acinetobacter baumannii is a nosocomial pathogen that has emerged as a
major threat in the health-care settings, particularly intensive care units (ICUs). The aim of …

Background Acinetobacter baumannii (AB) is critical for healthcare-associated infections
(HAI) with significant regional differences in the resistance rate, but its risk factors and …

Background Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a
significant challenge for antibiotic treatment and infection control policies. Since 2012, in …

Background Molecular analysis of carbapenem-resistant genes in Acinetobacter baumannii,
an emerging pathogen, is less commonly reported from Nepal. In this study we determined …